These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. South Korean biotechnology--a rising industrial and scientific powerhouse. Wong J; Quach U; Thorsteinsdóttir H; Singer PA; Daar AS Nat Biotechnol; 2004 Dec; 22 Suppl():DC42-7. PubMed ID: 15583684 [No Abstract] [Full Text] [Related]
31. The emergence of Egyptian biotechnology from generics. Abdelgafar B; Thorsteinsdóttir H; Quach U; Singer PA; Daar AS Nat Biotechnol; 2004 Dec; 22 Suppl():DC25-30. PubMed ID: 15583680 [No Abstract] [Full Text] [Related]
32. How to conduct competitive intelligence in your biotech startup. Finegold D; Carlucci S; Page A Nat Biotechnol; 2005 Jun; 23(6):651-3. PubMed ID: 16044490 [No Abstract] [Full Text] [Related]
33. Realizing potential: the state of Asian bioentrepreneurship. Tang CM; Mahmud MA; Foo FK; Chu SY; Chiu RI; Tanticharoen M; Zhang L; Chang TW Nat Biotechnol; 2003 Jul; 21 Suppl():BE15-22. PubMed ID: 12874972 [No Abstract] [Full Text] [Related]
34. Who took the tech out of biotech? Silverman E Nat Biotechnol; 2006 Mar; 24(3):255-6. PubMed ID: 16525373 [No Abstract] [Full Text] [Related]
35. Marriage guidance for collaborators. Hogan J Med Device Technol; 2005 Mar; 16(2):25-6. PubMed ID: 15828497 [TBL] [Abstract][Full Text] [Related]
36. A very firm handshake: biotech's growing negotiating power. Thiel KA Nat Biotechnol; 2005 Oct; 23(10):1221-6. PubMed ID: 16211058 [No Abstract] [Full Text] [Related]
37. University spin-offs: opportunity or challenge? Peng X Nat Mater; 2006 Dec; 5(12):923-5. PubMed ID: 17139301 [No Abstract] [Full Text] [Related]
38. The role of competitive intelligence in biotech startups. Carlucci S; Page A; Finegold D Nat Biotechnol; 2005 May; 23(5):525-7. PubMed ID: 15942983 [No Abstract] [Full Text] [Related]
39. Italian biotech too reliant on big pharma. Meldolesi A Nat Biotechnol; 2004 Aug; 22(8):1047. PubMed ID: 15309759 [No Abstract] [Full Text] [Related]
40. Reverse mergers attract top-tier biotechs in sluggish IPO market. Lawrence S Nat Biotechnol; 2006 Jun; 24(6):598-9. PubMed ID: 16763574 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]